Multiply Labs Raises $75 Million Series B to Close the Gap Between Drug Discovery and Drug Manufacturing

Summary

Multiply Labs raised $75 million in Series B funding to bridge the gap between drug discovery and drug manufacturing. The funding supports the company's efforts to streamline the transition from research to production.